| GSK
Pips Pfizer
August 21, 2003
GSK pips Pfizer to the post in
introducing its erectile
dysfunction drug into the US market By Stephen
Foley
The biggest drugmaker in the UK,
GlaxoSmithKline, has won approval to sell its
new impotence pill in the US setting the scene
for a giant battle against Pfizer's Viagra.
Article Length: 406 words (approx.)
. . . . . . . . .
Independent Portfolio Article
This article is available in full to Independent
Portfolio subscribers. Access it through
Already Subscribed ?
Otherwise, your options are:
£1 for 24 hours' access to this article;
£5 for a month's subscription to all
articles in this package (first month free);
£30 for a year's subscription to all
articles in this package;
£60 annual subscription to ALL Portfolio
content.
source:-http://news.independent.co.uk
|
